Hormone therapy may increase Alzheimer's risk, study finds

Hormone therapy may increase Alzheimer's risk, study finds

- in Health
13

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

By Shamard Charles, M.D.

Long-term use of oral hormone therapy may be associated with a small increased risk of Alzheimer’s disease in postmenopausal women, researchers reported Wednesday.

The Finnish study looked at nearly 85,000 postmenopausal women, between the ages of 70 and 80, diagnosed with Alzheimer’s disease between 1999 and 2013. The researchers found that use of oral hormone therapy for 10 or more years in women who started the pills before age 60 had a nine to 17 percent increased risk for Alzheimer’s disease. Women who used vaginal hormone therapy showed no increased risk.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like

PDX airport expansion takes shape amid Spring Break travel

PORTLAND, Ore. — Here comes Spring Break travel.